Dosing protocol · Healing & Recovery
Thymulin Analog (PAT) dosing & administration
Synthetic thymulin-derived nonapeptide with potent analgesic and anti-inflammatory properties
Suggested dose
1 mcg–50 mcg mcg
137 peptides · 10 goals
Goals
Cognitive
Cosmetic
Growth Hormone
Healing & Recovery
Hormone Support
Immune
Metabolic
Mitochondrial
Sexual Health
Sleep & Recovery
Dosing protocol · Healing & Recovery
Synthetic thymulin-derived nonapeptide with potent analgesic and anti-inflammatory properties
Suggested dose
1 mcg–50 mcg mcg
Dosing
Timing
Best time to take
Administer Thymulin Analog (PAT) at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.
With food?
Thymulin Analog (PAT) injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.
If stacking
Thymulin Analog (PAT) should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
Decrease if
Signs of right dose
Administration
Reconstitution
What you need
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Storage
Before reconstitution
Store Thymulin Analog (PAT) in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Thymulin Analog (PAT) should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Intraperitoneal injection—rotate sites if applicable
Maintain a consistent schedule for optimal results with Thymulin Analog (PAT). Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Side effects
Commonly reported: Injection Site Reaction, Transient Immune Modulation, Mild Sedation, Short Duration of Action
Less common: Potential Immune Suppression, CNS Effects with Central Administration
Serious side effects
Stop and seek help if
Thymulin Analog (PAT) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Flagged pairings
Published research
Targeting inflammatory components in neuropathic pain: The analgesic effect of thymulin related peptide
Thymulin-related peptides target inflammatory components in neuropathic pain by reducing cytokine-mediated neuroinflammation. These peptides regulate inflammatory mediators for novel therapeutic approaches to chronic pain.
Involvement of alpha-7 nicotinic acetylcholine receptors in the anti-inflammatory action of PAT
PAT demonstrated anti-inflammatory action through potentiation of alpha-7 nicotinic acetylcholine receptors, reversing inflammatory nociceptive hyperactivity in rats. The mechanism differed from traditional analgesics.
Role of thymulin or its analogue as a new analgesic molecule
No abstract available for comprehensive analysis.
A thymulin analogue peptide with powerful inhibitory effects on pain of neurogenic origin
Thymulin analog PAT produced powerful neuropathic pain reduction equal to morphine in chronic constriction and spared nerve injury models. Daily treatment progressively attenuated all neuropathic manifestations.
Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat
PAT significantly reduced inflammatory hyperalgesia in rats through dose-dependent decrease in pro-inflammatory cytokines. Analgesic effects matched dexamethasone and indomethacin.
Head to head
The complete Thymulin Analog (PAT) research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.